This compound was also tested for mu-opioid receptor action, and like conolidine, was discovered to acquire no activity at the positioning. Utilizing a similar paw injection exam, many options with higher efficacy had been identified that inhibited the initial discomfort response, indicating opiate-like activity. Given different mechanisms of those